GlaxoSmithKline
GSK
#111
Rank
$111.06 B
Marketcap
$43.69
Share price
2.20%
Change (1 day)
9.83%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: $111.06 Billion

As of June 2022 GlaxoSmithKline has a market cap of $111.06 Billion. This makes GlaxoSmithKline the world's 111th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 2001 to 2022

Year Market cap Change
2022$111.06 B1.79%
2021$109.10 B18.9%
2020$91.76 B-21.15%
2019$116.38 B23.9%
2018$93.93 B6.6%
2017$88.11 B-6.48%
2016$94.22 B-4.88%
2015$99.05 B-4.91%
2014$104.16 B-19.26%
2013$129.00 B21.97%
2012$105.76 B-8.18%
2011$115.19 B13.05%
2010$101.89 B-7.08%
2009$109.65 B13.45%
2008$96.66 B-30.35%
2007$138.78 B-8.6%
2006$151.83 B3.03%
2005$147.36 B4.74%
2004$140.69 B6.84%
2003$131.68 B16.71%
2002$112.83 B-26.62%
2001$153.76 B

End of Day market cap according to different sources

On Jun 26th, 2022 the market cap of GlaxoSmithKline was reported to be:

$111.06 Billion
by Yahoo Finance
$111.06 Billion
by CompaniesMarketCap
$111.06 Billion
by Nasdaq
$111.05 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$189.14 B 70.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$289.46 B 160.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$133.40 B 20.12%๐Ÿ‡ซ๐Ÿ‡ท France
$235.50 B 112.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$207.31 B 86.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
$8.82 B-92.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.55 B-98.60%๐Ÿ‡บ๐Ÿ‡ธ USA